6505--Radiopharmaceutical: Ioflupane (I-123) Tracer

The Department of Veterans Affairs intends to award a sole-source contract to Medi-Physics, Inc., doing business as GE Healthcare, for the provision of the radiopharmaceutical tracer Ioflupane I-123, commonly known as DaTscan. This procurement supports the Orlando VA Healthcare System located in Orlando, Florida. The acquisition is being conducted under the authority of 41 USC 3304(a)(1) as implemented by FAR 6.302-1, which applies when only one responsible source can satisfy agency requirements.

The requirement is classified under NAICS 325412, Pharmaceutical Preparation Manufacturing, and PSC 6505, Drugs and Biologicals. There is no set-aside designated for this action. Administrative details associated with the solicitation, numbered 36C24822Q0373, include two attachments: a Word document and a Limited Sources Justification in PDF format. Jessica Kiser serves as the primary point of contact for this notice.

Vendors asserting the technical capability to meet this specific need must submit a response by February 17, 2022, at 12:00 PM Eastern Standard Time. While the government intends to proceed with a single-source award for this requirement, any information received will be utilized to determine potential sources for future procurements. This special notice serves as the only announcement regarding the government's intent to solicit and award this contract.